László Gulácsi. Show Affiliations »
Abstract
Mesh: See more » Biological Products/economicsBiological Products/therapeutic useCosts and Cost AnalysisHumansIncidencePatient CompliancePrevalenceRandomized Controlled Trials as TopicRheumatic Diseases/drug therapyTechnology Assessment, Biomedical
Substances: See more » Biological Products
Year: 2010 PMID: 20401677 DOI: 10.1007/s10198-010-0246-2
Source DB: PubMed Journal: Eur J Health Econ ISSN: 1618-7598